Homebiotech

biotech

biotech

Topline results from metastatic breast cancer phase 3 trial

Jim Cornall - October 28, 2026

biotech

Updated prostate cancer results show anti-tumour activity

Jim Cornall - October 28, 2026

biotech

Gesynta Pharma continues endometriosis work

Jim Cornall - October 28, 2026

biotech

First-in-human circular RNA therapy for radiation-induced xerostomia

Jim Cornall - October 27, 2026

biotech

Collaboration to develop first medicine for newly identified ReNU syndrome

Jim Cornall - July 29, 2026

biotech

Body’s natural recycling system could help reduce inflammation

Jim Cornall - July 29, 2026

biotech

Crystalys Therapeutics raises $130m for gout treatment

Jim Cornall - July 29, 2026

biotech

Boost to biotech in Virginia with lab capacity increase

Jim Cornall - July 28, 2026

biotech

AI and sleep analysis help early diagnosis of Alzheimer’s

Jim Cornall - July 28, 2026

biotech

Taiwan positions itself as global biotech innovation partner at BIO Asia-Taiwan 2026

Jim Cornall - July 28, 2026

biotech

KAIST gives antibodies ‘eyes’ to detect cancer

Jim Cornall - July 27, 2026

biotech

GHIT Fund invests in portable rapid diagnostic system for Ebola disease

Jim Cornall - July 27, 2026

1...161718...108 Page 17 of 108

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Topline results from metastatic breast cancer phase 3 trial

Jim Cornall - October 28, 2026 0

BioNTech SE and DualityBiologics (Suzhou) Co., Ltd. have announced that the DYNASTY-Breast02 global phase 3 clinical trial met its primary endpoint. This demonstrated a statistically...

Updated prostate cancer results show anti-tumour activity

biotech Jim Cornall - October 28, 2026 0

Gesynta Pharma continues endometriosis work

biotech Jim Cornall - October 28, 2026 0

First-in-human circular RNA therapy for radiation-induced xerostomia

biotech Jim Cornall - October 27, 2026 0

Data show unresectable patients becoming eligible for surgery

biotech Jim Cornall - October 27, 2026 0